Evidence map›Paper›PMID 28922371›Full record

Trial reportPloS one2017

The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Martin Tibuakuu, Daisuke Kamimura, Sina Kianoush, Andrew P DeFilippis, Mahmoud Al Rifai, Lindsay M Reynolds, Wendy B White, Kenneth R Butler, Thomas H Mosley, Stephen T Turner and 3 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Portable air cleaner use and biomarkers of inflammation: A systematic review and meta-analysis.American heart journal plus : cardiology research and practice · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Martin TibuakuuCiccarone Center for the Prevention of Heart Disease, Johns Hopkins School of Medicine, Baltimore, United States of America.ORCID http://orcid.org/0000-0001-8644-6086
Daisuke KamimuraUniversity of Mississippi Medical Center, Division of Cardiology, Jackson, United States of America.
Sina KianoushCiccarone Center for the Prevention of Heart Disease, Johns Hopkins School of Medicine, Baltimore, United States of America.
Andrew P DeFilippisDivision of Cardiology, University of Louisville School of Medicine, Louisville, United States of America.
Mahmoud Al RifaiCiccarone Center for the Prevention of Heart Disease, Johns Hopkins School of Medicine, Baltimore, United States of America.
Lindsay M ReynoldsDepartment of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, United States of America.
Wendy B WhiteJackson Heart Study, Tougaloo College, Jackson, United States of America.
Kenneth R ButlerUniversity of Mississippi Medical Center, Department of Medicine, Jackson, United States of America.
Thomas H MosleyUniversity of Mississippi Medical Center, Department of Medicine, Jackson, United States of America.
Stephen T TurnerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, United States of America.
Iftikhar J KulloDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, United States of America.
Michael E HallUniversity of Mississippi Medical Center, Division of Cardiology, Jackson, United States of America.
Michael J BlahaCiccarone Center for the Prevention of Heart Disease, Johns Hopkins School of Medicine, Baltimore, United States of America.
Jackson Memorial Hospital · USJohns Hopkins University · USMayo Clinic · USMayo Clinic in Florida · USTougaloo College · USUniversity of Louisville · USWake Forest University · US

Funding

Research Training and Education Core (Core D) P50HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI ROBERTSON, ROSE MARIE · 2013 to 2017
$20.1M
ConProject-006U54HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2018 to 2022
$18.8M
Proteomic Markers of ArteriosclerosisU01HL081331 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2005 to 2008
$3.7M
NHLBI FAMILY BLOOD PRESSURE PROGRAM (GENOA)U01HL054464 · NHLBI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI TURNER, STEPHEN T · 2000 to 2004
$2.6M
GENETIC DETERMINANTS OF HIGH BLOOD PRESSURE (GENOA)U01HL054463 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI MOSLEY, THOMAS H · 2000 to 2004
$1.6M
Renal Sinus Fat, Hypertension, and Altered Kidney FunctionK08DK099415 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI HALL, MICHAEL EDWARD · 2015 to 2019
$791k
NHLBI NIH HHS P50 HL120163NHLBI NIH HHS U01 HL054463NHLBI NIH HHS U01 HL054464NHLBI NIH HHS U01 HL081331NHLBI NIH HHS U54 HL120163NIDDK NIH HHS K08 DK099415
6 · The paper itself

Abstract

To inform the study and regulation of emerging tobacco products, we sought to identify sensitive biomarkers of tobacco-induced subclinical cardiovascular damage by testing the cross-sectional associations of smoking with 17 biomarkers of inflammation in 2,702 GENOA study participants belonging to sibships ascertained on the basis of hypertension. Cigarette smoking was assessed by status, intensity (number of cigarettes per day), burden (pack-years of smoking), and time since quitting. We modeled biomarkers as geometric mean (GM) ratios using generalized estimating equations (GEE). The mean age of participants was 61 ±10 years; 64.5% were women and 54.4% African American. The prevalence of smoking was 12.2%. After adjusting for potential confounders, 6 of 17 biomarkers were significantly higher among current smokers at a Bonferroni adjusted p-value threshold (p<0.003). High sensitivity C-reactive protein was the most elevated biomarker among current smokers when compared to never smokers [GM ratio = 1.39 (95% CI: 1.23, 1.57); p <0.001]. Among former smokers, each pack-year of cigarettes smoked was associated with a 0.4% higher serum level of hsCRP [GM ratio = 1.004 (95% CI: 1.001, 1.006); p = 0.002] and each 5-year lapsed since quitting was associated with a 4% lower serum level of hsCRP [GM ratio = 0.96 (95% CI: 0.93, 0.99); p = 0.006]. However, we found no significant association of smoking intensity or burden with biomarkers of inflammation among current smokers. HsCRP appears to be the most sensitive biomarker of inflammation associated with cigarette smoking of those investigated, and could be a useful biomarker of smoking-related injury for the study and regulation of emerging tobacco products.

Indexed as

AgedBiomarkersC-Reactive ProteinFemaleHumansInflammationMaleMiddle AgedMolecular EpidemiologyPrevalenceSmokingBiomarkersC-Reactive Protein

Identifiers

PMID28922371
PMCPMC5602636
OpenAlexW2755987639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.